This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106a-5p | AADAC | -0.46 | 0.00972 | -1.53 | 0 | MirTarget | -0.23 | 0.00808 | NA | |
2 | hsa-miR-106b-5p | AADAC | 0.65 | 0 | -1.53 | 0 | MirTarget | -0.77 | 0 | NA | |
3 | hsa-miR-93-5p | AADAC | 1.4 | 0 | -1.53 | 0 | MirTarget | -0.44 | 6.0E-5 | NA | |
4 | hsa-miR-106b-5p | ABCA1 | 0.65 | 0 | -1.1 | 0 | MirTarget; miRNATAP | -0.19 | 0.00194 | NA | |
5 | hsa-miR-93-5p | ABCA1 | 1.4 | 0 | -1.1 | 0 | MirTarget; miRNATAP | -0.2 | 5.0E-5 | NA | |
6 | hsa-miR-106a-5p | ABHD2 | -0.46 | 0.00972 | -1.2 | 0 | miRNATAP | -0.11 | 0.00947 | NA | |
7 | hsa-miR-106b-5p | ABHD2 | 0.65 | 0 | -1.2 | 0 | miRNATAP | -0.46 | 0 | NA | |
8 | hsa-miR-93-5p | ABHD2 | 1.4 | 0 | -1.2 | 0 | miRNATAP | -0.47 | 0 | NA | |
9 | hsa-miR-106b-5p | ABHD5 | 0.65 | 0 | -0.6 | 0 | MirTarget | -0.19 | 1.0E-5 | NA | |
10 | hsa-miR-93-5p | ABHD5 | 1.4 | 0 | -0.6 | 0 | MirTarget | -0.21 | 0 | NA | |
11 | hsa-miR-20a-3p | ABLIM1 | -0.32 | 0.04679 | 0.05 | 0.66786 | mirMAP | -0.15 | 0 | NA | |
12 | hsa-miR-106b-5p | ABTB2 | 0.65 | 0 | -0.43 | 0.0031 | miRNAWalker2 validate | -0.25 | 5.0E-5 | NA | |
13 | hsa-miR-106a-5p | ACOX1 | -0.46 | 0.00972 | -1.16 | 0 | mirMAP | -0.12 | 0.00203 | NA | |
14 | hsa-miR-106b-5p | ACOX1 | 0.65 | 0 | -1.16 | 0 | mirMAP | -0.51 | 0 | NA | |
15 | hsa-miR-93-5p | ACOX1 | 1.4 | 0 | -1.16 | 0 | mirMAP | -0.41 | 0 | NA | |
16 | hsa-miR-106a-5p | ACSL6 | -0.46 | 0.00972 | 0.39 | 0.26458 | mirMAP | -0.57 | 0 | NA | |
17 | hsa-miR-106b-5p | ACSL6 | 0.65 | 0 | 0.39 | 0.26458 | mirMAP | -0.64 | 2.0E-5 | NA | |
18 | hsa-miR-106a-5p | ACTR3C | -0.46 | 0.00972 | -0.99 | 0 | mirMAP | -0.15 | 0.00144 | NA | |
19 | hsa-miR-106b-5p | ACTR3C | 0.65 | 0 | -0.99 | 0 | mirMAP | -0.5 | 0 | NA | |
20 | hsa-miR-93-5p | ACTR3C | 1.4 | 0 | -0.99 | 0 | mirMAP | -0.34 | 0 | NA | |
21 | hsa-miR-106b-5p | ADARB1 | 0.65 | 0 | -0.13 | 0.22208 | MirTarget | -0.22 | 0 | NA | |
22 | hsa-miR-20a-3p | ADARB1 | -0.32 | 0.04679 | -0.13 | 0.22208 | mirMAP | -0.15 | 0 | NA | |
23 | hsa-miR-93-5p | ADARB1 | 1.4 | 0 | -0.13 | 0.22208 | miRNAWalker2 validate; MirTarget | -0.21 | 0 | NA | |
24 | hsa-miR-106b-5p | ADCY1 | 0.65 | 0 | -2.7 | 0 | mirMAP | -0.54 | 0.00112 | NA | |
25 | hsa-miR-93-5p | ADCY1 | 1.4 | 0 | -2.7 | 0 | mirMAP | -0.65 | 0 | NA | |
26 | hsa-miR-106b-5p | ADCY9 | 0.65 | 0 | -0.11 | 0.30518 | mirMAP | -0.23 | 0 | NA | |
27 | hsa-miR-93-5p | ADCY9 | 1.4 | 0 | -0.11 | 0.30518 | mirMAP | -0.14 | 0.0003 | NA | |
28 | hsa-miR-106b-5p | ADH5 | 0.65 | 0 | -0.53 | 0 | miRNAWalker2 validate | -0.27 | 0 | NA | |
29 | hsa-miR-106b-5p | ADRA2A | 0.65 | 0 | -0.76 | 0.02558 | miRNATAP | -0.6 | 3.0E-5 | NA | |
30 | hsa-miR-106a-5p | AEN | -0.46 | 0.00972 | 0.28 | 0.01239 | MirTarget | -0.13 | 1.0E-5 | NA | |
31 | hsa-miR-106b-5p | AFF4 | 0.65 | 0 | -0.64 | 0 | miRNATAP | -0.27 | 0 | NA | |
32 | hsa-miR-93-5p | AFF4 | 1.4 | 0 | -0.64 | 0 | miRNATAP | -0.27 | 0 | NA | |
33 | hsa-miR-106b-5p | AGA | 0.65 | 0 | 0.02 | 0.86356 | MirTarget | -0.17 | 0.00102 | NA | |
34 | hsa-miR-106a-5p | AGFG2 | -0.46 | 0.00972 | -0.02 | 0.87061 | miRNATAP | -0.16 | 0 | NA | |
35 | hsa-miR-20a-3p | AGFG2 | -0.32 | 0.04679 | -0.02 | 0.87061 | mirMAP | -0.12 | 0.00068 | NA | |
36 | hsa-miR-20a-3p | AIFM1 | -0.32 | 0.04679 | -0.39 | 0.00049 | miRNATAP | -0.11 | 0.00067 | NA | |
37 | hsa-miR-106b-5p | AKAP11 | 0.65 | 0 | -0.7 | 0 | miRNAWalker2 validate | -0.25 | 0 | NA | |
38 | hsa-miR-93-5p | AKAP11 | 1.4 | 0 | -0.7 | 0 | miRNAWalker2 validate | -0.25 | 0 | NA | |
39 | hsa-miR-106b-5p | AKAP13 | 0.65 | 0 | -0.32 | 0.00142 | MirTarget; mirMAP; miRNATAP | -0.23 | 0 | NA | |
40 | hsa-miR-93-5p | AKAP13 | 1.4 | 0 | -0.32 | 0.00142 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
41 | hsa-miR-20a-3p | AKAP6 | -0.32 | 0.04679 | -0.97 | 0 | MirTarget | -0.3 | 0 | NA | |
42 | hsa-miR-93-5p | AKIRIN1 | 1.4 | 0 | -0.73 | 0 | mirMAP | -0.14 | 2.0E-5 | NA | |
43 | hsa-miR-106b-5p | AKT3 | 0.65 | 0 | -0.66 | 0.00047 | miRNATAP | -0.26 | 0.00148 | NA | |
44 | hsa-miR-93-5p | AKT3 | 1.4 | 0 | -0.66 | 0.00047 | miRNATAP | -0.28 | 1.0E-5 | NA | |
45 | hsa-miR-106a-5p | AKTIP | -0.46 | 0.00972 | -0.37 | 0.00054 | MirTarget; miRNATAP | -0.12 | 3.0E-5 | NA | |
46 | hsa-miR-106b-5p | AKTIP | 0.65 | 0 | -0.37 | 0.00054 | MirTarget; miRNATAP | -0.36 | 0 | NA | |
47 | hsa-miR-93-5p | AKTIP | 1.4 | 0 | -0.37 | 0.00054 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
48 | hsa-miR-93-5p | ALDH1A3 | 1.4 | 0 | -2.13 | 0 | mirMAP | -0.81 | 0 | NA | |
49 | hsa-miR-106b-5p | ALDH3A2 | 0.65 | 0 | -0.55 | 0.00022 | mirMAP | -0.45 | 0 | NA | |
50 | hsa-miR-20a-3p | ALDH3A2 | -0.32 | 0.04679 | -0.55 | 0.00022 | mirMAP | -0.14 | 0.00285 | NA | |
51 | hsa-miR-20a-3p | ANGPTL1 | -0.32 | 0.04679 | -2.91 | 0 | MirTarget | -0.36 | 0.00116 | NA | |
52 | hsa-miR-93-5p | ANK2 | 1.4 | 0 | -0.94 | 8.0E-5 | MirTarget; miRNATAP | -0.24 | 0.00324 | NA | |
53 | hsa-miR-106b-5p | ANKFY1 | 0.65 | 0 | -0.58 | 0 | miRNAWalker2 validate; MirTarget | -0.24 | 0 | NA | |
54 | hsa-miR-20a-3p | ANKFY1 | -0.32 | 0.04679 | -0.58 | 0 | MirTarget | -0.1 | 0.00012 | NA | |
55 | hsa-miR-93-5p | ANKFY1 | 1.4 | 0 | -0.58 | 0 | miRNAWalker2 validate | -0.22 | 0 | NA | |
56 | hsa-miR-93-5p | ANKH | 1.4 | 0 | -0.35 | 0.00159 | MirTarget | -0.1 | 0.00683 | NA | |
57 | hsa-miR-93-5p | ANKRD12 | 1.4 | 0 | -0.35 | 0.00044 | MirTarget | -0.12 | 0.00046 | NA | |
58 | hsa-miR-106a-5p | ANKRD29 | -0.46 | 0.00972 | 1.13 | 4.0E-5 | MirTarget | -0.48 | 0 | NA | |
59 | hsa-miR-106b-5p | ANKRD29 | 0.65 | 0 | 1.13 | 4.0E-5 | MirTarget | -0.64 | 0 | NA | |
60 | hsa-miR-93-5p | ANKRD29 | 1.4 | 0 | 1.13 | 4.0E-5 | miRNAWalker2 validate; MirTarget | -0.37 | 0.0001 | NA | |
61 | hsa-miR-20a-3p | ANKRD50 | -0.32 | 0.04679 | -0.25 | 0.04433 | MirTarget; miRNATAP | -0.14 | 0.00021 | NA | |
62 | hsa-miR-93-5p | ANKRD50 | 1.4 | 0 | -0.25 | 0.04433 | MirTarget; miRNATAP | -0.16 | 0.00022 | NA | |
63 | hsa-miR-106b-5p | ANO6 | 0.65 | 0 | -0.29 | 0.00464 | MirTarget | -0.14 | 0.00107 | NA | |
64 | hsa-miR-93-5p | ANO6 | 1.4 | 0 | -0.29 | 0.00464 | MirTarget; miRNATAP | -0.11 | 0.0016 | NA | |
65 | hsa-miR-93-5p | AP1AR | 1.4 | 0 | -0.61 | 0 | miRNAWalker2 validate | -0.26 | 0 | NA | |
66 | hsa-miR-106b-5p | AP1G1 | 0.65 | 0 | -0.48 | 0 | miRNAWalker2 validate | -0.28 | 0 | NA | |
67 | hsa-miR-93-5p | AP1G1 | 1.4 | 0 | -0.48 | 0 | miRNAWalker2 validate | -0.25 | 0 | NA | |
68 | hsa-miR-106b-5p | AP3S2 | 0.65 | 0 | -0.33 | 4.0E-5 | mirMAP | -0.2 | 0 | NA | |
69 | hsa-miR-93-5p | AP3S2 | 1.4 | 0 | -0.33 | 4.0E-5 | mirMAP | -0.17 | 0 | NA | |
70 | hsa-miR-106a-5p | APBB2 | -0.46 | 0.00972 | -0.24 | 0.03085 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
71 | hsa-miR-106b-5p | APBB2 | 0.65 | 0 | -0.24 | 0.03085 | MirTarget; miRNATAP | -0.21 | 1.0E-5 | NA | |
72 | hsa-miR-93-5p | APBB2 | 1.4 | 0 | -0.24 | 0.03085 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.17 | 0 | NA | |
73 | hsa-miR-106b-5p | APC | 0.65 | 0 | -0.18 | 0.06792 | miRNAWalker2 validate; miRTarBase | -0.15 | 0.00024 | 23087084 | miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells |
74 | hsa-miR-20a-3p | APC2 | -0.32 | 0.04679 | 1.72 | 0 | mirMAP | -0.25 | 7.0E-5 | NA | |
75 | hsa-miR-106a-5p | AR | -0.46 | 0.00972 | -2.66 | 0 | mirMAP | -0.48 | 2.0E-5 | NA | |
76 | hsa-miR-106b-5p | AR | 0.65 | 0 | -2.66 | 0 | mirMAP | -1.42 | 0 | NA | |
77 | hsa-miR-93-5p | AR | 1.4 | 0 | -2.66 | 0 | mirMAP | -1.11 | 0 | NA | |
78 | hsa-miR-93-5p | ARAP2 | 1.4 | 0 | -1.13 | 0 | MirTarget | -0.33 | 0 | NA | |
79 | hsa-miR-106b-5p | ARHGAP23 | 0.65 | 0 | -0.14 | 0.32985 | mirMAP | -0.31 | 0 | NA | |
80 | hsa-miR-93-5p | ARHGAP23 | 1.4 | 0 | -0.14 | 0.32985 | mirMAP | -0.27 | 0 | NA | |
81 | hsa-miR-106b-5p | ARHGAP24 | 0.65 | 0 | -0.99 | 0 | MirTarget | -0.32 | 3.0E-5 | NA | |
82 | hsa-miR-93-5p | ARHGAP24 | 1.4 | 0 | -0.99 | 0 | MirTarget | -0.4 | 0 | NA | |
83 | hsa-miR-106b-5p | ARID4A | 0.65 | 0 | -0.9 | 0 | MirTarget; miRNATAP | -0.14 | 0.00925 | NA | |
84 | hsa-miR-93-5p | ARID4A | 1.4 | 0 | -0.9 | 0 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
85 | hsa-miR-93-5p | ARL10 | 1.4 | 0 | -0.42 | 0.01556 | mirMAP | -0.2 | 0.00063 | NA | |
86 | hsa-miR-106b-5p | ARSB | 0.65 | 0 | 0 | 0.99867 | mirMAP | -0.15 | 0.00457 | NA | |
87 | hsa-miR-106a-5p | ARSD | -0.46 | 0.00972 | -1.16 | 0 | mirMAP | -0.2 | 0 | NA | |
88 | hsa-miR-106b-5p | ARSD | 0.65 | 0 | -1.16 | 0 | mirMAP | -0.48 | 0 | NA | |
89 | hsa-miR-93-5p | ARSJ | 1.4 | 0 | -1.41 | 0 | miRNAWalker2 validate | -0.44 | 0 | NA | |
90 | hsa-miR-20a-3p | ASAP2 | -0.32 | 0.04679 | 0.69 | 2.0E-5 | MirTarget | -0.32 | 0 | NA | |
91 | hsa-miR-106b-5p | ASPA | 0.65 | 0 | -2.88 | 0 | mirMAP | -0.58 | 0 | NA | |
92 | hsa-miR-93-5p | ASPA | 1.4 | 0 | -2.88 | 0 | mirMAP | -0.79 | 0 | NA | |
93 | hsa-miR-106b-5p | ATE1 | 0.65 | 0 | -0.6 | 0.0009 | MirTarget | -0.21 | 0.00742 | NA | |
94 | hsa-miR-93-5p | ATE1 | 1.4 | 0 | -0.6 | 0.0009 | MirTarget | -0.25 | 5.0E-5 | NA | |
95 | hsa-miR-106b-5p | ATF6 | 0.65 | 0 | -0.02 | 0.87055 | mirMAP | -0.25 | 0 | NA | |
96 | hsa-miR-93-5p | ATF6 | 1.4 | 0 | -0.02 | 0.87055 | mirMAP | -0.16 | 1.0E-5 | NA | |
97 | hsa-miR-106b-5p | ATG2A | 0.65 | 0 | -0.78 | 0 | miRNATAP | -0.15 | 0.00025 | NA | |
98 | hsa-miR-93-5p | ATG2A | 1.4 | 0 | -0.78 | 0 | miRNATAP | -0.2 | 0 | NA | |
99 | hsa-miR-106a-5p | ATP1A2 | -0.46 | 0.00972 | 0.51 | 0.11121 | MirTarget | -0.24 | 0.00583 | NA | |
100 | hsa-miR-106b-5p | ATP1A2 | 0.65 | 0 | 0.51 | 0.11121 | MirTarget; miRNATAP | -0.67 | 0 | NA | |
101 | hsa-miR-93-5p | ATP1A2 | 1.4 | 0 | 0.51 | 0.11121 | MirTarget | -0.29 | 0.00874 | NA | |
102 | hsa-miR-93-5p | ATP5B | 1.4 | 0 | -0.12 | 0.15018 | miRNAWalker2 validate | -0.12 | 3.0E-5 | NA | |
103 | hsa-miR-106a-5p | ATXN1L | -0.46 | 0.00972 | 0.09 | 0.38956 | miRNATAP | -0.11 | 0.00013 | NA | |
104 | hsa-miR-93-5p | B2M | 1.4 | 0 | -0.47 | 0.00029 | miRNAWalker2 validate | -0.39 | 0 | NA | |
105 | hsa-miR-93-5p | BACH1 | 1.4 | 0 | -0.63 | 0 | mirMAP | -0.14 | 0.00086 | NA | |
106 | hsa-miR-20a-3p | BCL2 | -0.32 | 0.04679 | -0.35 | 0.02497 | mirMAP | -0.24 | 0 | NA | |
107 | hsa-miR-93-5p | BHLHE41 | 1.4 | 0 | -0.4 | 0.15906 | miRNATAP | -0.3 | 0.00244 | NA | |
108 | hsa-miR-106b-5p | BMPR2 | 0.65 | 0 | -0.74 | 0 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
109 | hsa-miR-93-5p | BMPR2 | 1.4 | 0 | -0.74 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.27 | 0 | NA | |
110 | hsa-miR-106b-5p | BNC2 | 0.65 | 0 | -0.39 | 0.08973 | miRNATAP | -0.35 | 0.00032 | NA | |
111 | hsa-miR-93-5p | BNC2 | 1.4 | 0 | -0.39 | 0.08973 | miRNATAP | -0.4 | 0 | NA | |
112 | hsa-miR-106b-5p | BNIP2 | 0.65 | 0 | -0.74 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
113 | hsa-miR-93-5p | BNIP2 | 1.4 | 0 | -0.74 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.21 | 0 | NA | |
114 | hsa-miR-106b-5p | BNIP3L | 0.65 | 0 | -0.67 | 0 | MirTarget | -0.15 | 0.0011 | NA | |
115 | hsa-miR-93-5p | BNIP3L | 1.4 | 0 | -0.67 | 0 | MirTarget | -0.12 | 0.00081 | NA | |
116 | hsa-miR-93-5p | BRMS1L | 1.4 | 0 | -0.38 | 0 | MirTarget; miRNATAP | -0.12 | 2.0E-5 | NA | |
117 | hsa-miR-106b-5p | BTN3A3 | 0.65 | 0 | -0.38 | 0.00816 | miRNAWalker2 validate | -0.42 | 0 | NA | |
118 | hsa-miR-106b-5p | C14orf28 | 0.65 | 0 | -0.34 | 0.00119 | miRNATAP | -0.21 | 0 | NA | |
119 | hsa-miR-93-5p | C14orf28 | 1.4 | 0 | -0.34 | 0.00119 | miRNATAP | -0.12 | 0.00058 | NA | |
120 | hsa-miR-106a-5p | C16orf52 | -0.46 | 0.00972 | -0.5 | 0 | miRNATAP | -0.12 | 2.0E-5 | NA | |
121 | hsa-miR-106b-5p | C16orf52 | 0.65 | 0 | -0.5 | 0 | miRNATAP | -0.28 | 0 | NA | |
122 | hsa-miR-93-5p | C16orf52 | 1.4 | 0 | -0.5 | 0 | miRNATAP | -0.2 | 0 | NA | |
123 | hsa-miR-106b-5p | C16orf70 | 0.65 | 0 | -0.77 | 0 | miRNATAP | -0.36 | 0 | NA | |
124 | hsa-miR-93-5p | C16orf87 | 1.4 | 0 | -0.85 | 0 | mirMAP | -0.26 | 0 | NA | |
125 | hsa-miR-20a-3p | C17orf51 | -0.32 | 0.04679 | -0.67 | 0.00164 | mirMAP | -0.22 | 0.00089 | NA | |
126 | hsa-miR-20a-3p | C1orf21 | -0.32 | 0.04679 | -0.75 | 0.00045 | mirMAP | -0.26 | 9.0E-5 | NA | |
127 | hsa-miR-106b-5p | C3orf70 | 0.65 | 0 | 0.49 | 0.00136 | miRNATAP | -0.19 | 0.00352 | NA | |
128 | hsa-miR-106b-5p | C4orf3 | 0.65 | 0 | -0.76 | 0 | mirMAP | -0.31 | 0 | NA | |
129 | hsa-miR-20a-3p | CACNB4 | -0.32 | 0.04679 | 1.93 | 0 | miRNATAP | -0.38 | 3.0E-5 | NA | |
130 | hsa-miR-20a-3p | CADPS2 | -0.32 | 0.04679 | 0.02 | 0.88551 | MirTarget | -0.15 | 0.00104 | NA | |
131 | hsa-miR-93-5p | CALCOCO2 | 1.4 | 0 | -0.31 | 1.0E-5 | miRNAWalker2 validate | -0.15 | 0 | NA | |
132 | hsa-miR-106b-5p | CALD1 | 0.65 | 0 | -0.53 | 0 | miRNATAP | -0.31 | 0 | NA | |
133 | hsa-miR-93-5p | CALD1 | 1.4 | 0 | -0.53 | 0 | miRNATAP | -0.23 | 0 | NA | |
134 | hsa-miR-106a-5p | CALML4 | -0.46 | 0.00972 | 0.01 | 0.91319 | mirMAP | -0.11 | 0.0004 | NA | |
135 | hsa-miR-20a-3p | CAMK1D | -0.32 | 0.04679 | -0.4 | 0.12354 | mirMAP | -0.5 | 0 | NA | |
136 | hsa-miR-106b-5p | CAMTA2 | 0.65 | 0 | -0.35 | 8.0E-5 | MirTarget | -0.15 | 8.0E-5 | NA | |
137 | hsa-miR-93-5p | CAMTA2 | 1.4 | 0 | -0.35 | 8.0E-5 | MirTarget | -0.14 | 1.0E-5 | NA | |
138 | hsa-miR-20a-3p | CAPN2 | -0.32 | 0.04679 | 0.66 | 0 | MirTarget | -0.13 | 0.00067 | NA | |
139 | hsa-miR-106b-5p | CASC4 | 0.65 | 0 | -0.46 | 0 | MirTarget | -0.23 | 0 | NA | |
140 | hsa-miR-93-5p | CASC4 | 1.4 | 0 | -0.46 | 0 | MirTarget | -0.25 | 0 | NA | |
141 | hsa-miR-106a-5p | CASK | -0.46 | 0.00972 | 0.43 | 0.00011 | mirMAP | -0.1 | 0.00062 | NA | |
142 | hsa-miR-20a-3p | CASK | -0.32 | 0.04679 | 0.43 | 0.00011 | mirMAP | -0.22 | 0 | NA | |
143 | hsa-miR-93-5p | CAV2 | 1.4 | 0 | -0.67 | 0.00155 | miRNAWalker2 validate | -0.26 | 0.00029 | NA | |
144 | hsa-miR-106b-5p | CBLN4 | 0.65 | 0 | -1.67 | 0.00015 | miRNATAP | -1.04 | 0 | NA | |
145 | hsa-miR-106a-5p | CBX7 | -0.46 | 0.00972 | -0.08 | 0.52937 | mirMAP | -0.2 | 0 | NA | |
146 | hsa-miR-106b-5p | CBX7 | 0.65 | 0 | -0.08 | 0.52937 | mirMAP | -0.33 | 0 | NA | |
147 | hsa-miR-93-5p | CBX7 | 1.4 | 0 | -0.08 | 0.52937 | mirMAP | -0.19 | 0 | NA | |
148 | hsa-miR-106a-5p | CC2D1A | -0.46 | 0.00972 | 0.26 | 0.00869 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
149 | hsa-miR-106b-5p | CCBE1 | 0.65 | 0 | -5.46 | 0 | mirMAP | -1.06 | 0 | NA | |
150 | hsa-miR-93-5p | CCBE1 | 1.4 | 0 | -5.46 | 0 | mirMAP | -1.25 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | INTRACELLULAR SIGNAL TRANSDUCTION | 111 | 1572 | 7.002e-12 | 3.258e-08 |
2 | RESPONSE TO ENDOGENOUS STIMULUS | 103 | 1450 | 3.22e-11 | 7.492e-08 |
3 | REGULATION OF CELL DIFFERENTIATION | 104 | 1492 | 7.632e-11 | 1.184e-07 |
4 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 66 | 788 | 2.35e-10 | 2.187e-07 |
5 | CIRCULATORY SYSTEM DEVELOPMENT | 66 | 788 | 2.35e-10 | 2.187e-07 |
6 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 110 | 1672 | 6.08e-10 | 4.042e-07 |
7 | REGULATION OF PROTEIN MODIFICATION PROCESS | 112 | 1710 | 5.347e-10 | 4.042e-07 |
8 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 100 | 1492 | 1.569e-09 | 8.603e-07 |
9 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 106 | 1618 | 1.664e-09 | 8.603e-07 |
10 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 113 | 1791 | 3.816e-09 | 1.646e-06 |
11 | TISSUE DEVELOPMENT | 100 | 1518 | 3.892e-09 | 1.646e-06 |
12 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 74 | 1008 | 6.471e-09 | 2.509e-06 |
13 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 105 | 1656 | 1.158e-08 | 3.931e-06 |
14 | CELL DEVELOPMENT | 94 | 1426 | 1.183e-08 | 3.931e-06 |
15 | POSITIVE REGULATION OF CATABOLIC PROCESS | 39 | 395 | 1.717e-08 | 5.326e-06 |
16 | TELENCEPHALON DEVELOPMENT | 28 | 228 | 1.885e-08 | 5.481e-06 |
17 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 79 | 1135 | 2.01e-08 | 5.501e-06 |
18 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 110 | 1784 | 2.215e-08 | 5.725e-06 |
19 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 116 | 1929 | 3.398e-08 | 8.321e-06 |
20 | NEGATIVE REGULATION OF CELL COMMUNICATION | 81 | 1192 | 3.731e-08 | 8.681e-06 |
21 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 112 | 1848 | 4.06e-08 | 8.988e-06 |
22 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 89 | 1360 | 4.25e-08 | 8.988e-06 |
23 | HEART DEVELOPMENT | 42 | 466 | 6.615e-08 | 1.338e-05 |
24 | REGULATION OF KINASE ACTIVITY | 59 | 776 | 7.325e-08 | 1.42e-05 |
25 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 54 | 689 | 1.009e-07 | 1.878e-05 |
26 | REGULATION OF TRANSFERASE ACTIVITY | 67 | 946 | 1.37e-07 | 2.451e-05 |
27 | HOMEOSTATIC PROCESS | 86 | 1337 | 1.566e-07 | 2.682e-05 |
28 | MUSCLE CELL DIFFERENTIATION | 27 | 237 | 1.614e-07 | 2.682e-05 |
29 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 14 | 70 | 1.818e-07 | 2.917e-05 |
30 | POSITIVE REGULATION OF GENE EXPRESSION | 104 | 1733 | 2.178e-07 | 3.269e-05 |
31 | VASCULATURE DEVELOPMENT | 41 | 469 | 2.165e-07 | 3.269e-05 |
32 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 94 | 1518 | 2.249e-07 | 3.27e-05 |
33 | REGULATION OF CATABOLIC PROCESS | 55 | 731 | 2.892e-07 | 3.958e-05 |
34 | NEGATIVE REGULATION OF PHOSPHORYLATION | 38 | 422 | 2.873e-07 | 3.958e-05 |
35 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 57 | 771 | 3.111e-07 | 4.136e-05 |
36 | NEUROGENESIS | 88 | 1402 | 3.219e-07 | 4.16e-05 |
37 | FOREBRAIN DEVELOPMENT | 34 | 357 | 3.338e-07 | 4.198e-05 |
38 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 26 | 232 | 3.768e-07 | 4.614e-05 |
39 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 114 | 1977 | 4.054e-07 | 4.836e-05 |
40 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 106 | 1805 | 4.685e-07 | 5.45e-05 |
41 | EPITHELIUM DEVELOPMENT | 65 | 945 | 5.997e-07 | 6.806e-05 |
42 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 86 | 1381 | 6.19e-07 | 6.857e-05 |
43 | POSITIVE REGULATION OF CELL COMMUNICATION | 93 | 1532 | 6.34e-07 | 6.86e-05 |
44 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 21 | 166 | 6.822e-07 | 7.214e-05 |
45 | PALLIUM DEVELOPMENT | 20 | 153 | 7.401e-07 | 7.653e-05 |
46 | CHEMICAL HOMEOSTASIS | 61 | 874 | 8.376e-07 | 8.297e-05 |
47 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 69 | 1036 | 8.559e-07 | 8.297e-05 |
48 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 69 | 1036 | 8.559e-07 | 8.297e-05 |
49 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 30 | 306 | 8.928e-07 | 8.478e-05 |
50 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 67 | 1004 | 1.163e-06 | 0.0001083 |
51 | MUSCLE STRUCTURE DEVELOPMENT | 37 | 432 | 1.383e-06 | 0.0001238 |
52 | TRANSITION METAL ION HOMEOSTASIS | 16 | 106 | 1.378e-06 | 0.0001238 |
53 | PROTEIN CATABOLIC PROCESS | 45 | 579 | 1.505e-06 | 0.0001297 |
54 | BLOOD VESSEL MORPHOGENESIS | 33 | 364 | 1.496e-06 | 0.0001297 |
55 | RESPONSE TO HORMONE | 61 | 893 | 1.696e-06 | 0.0001435 |
56 | NEURON DIFFERENTIATION | 60 | 874 | 1.766e-06 | 0.0001467 |
57 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 37 | 437 | 1.816e-06 | 0.0001483 |
58 | REGULATION OF CELL DEVELOPMENT | 58 | 836 | 1.902e-06 | 0.0001526 |
59 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 56 | 799 | 2.111e-06 | 0.0001615 |
60 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 67 | 1021 | 2.077e-06 | 0.0001615 |
61 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 53 | 740 | 2.118e-06 | 0.0001615 |
62 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 41 | 513 | 2.206e-06 | 0.0001629 |
63 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 29 | 303 | 2.2e-06 | 0.0001629 |
64 | REGULATION OF NEURON DIFFERENTIATION | 43 | 554 | 2.665e-06 | 0.0001938 |
65 | REGULATION OF CELL PROJECTION ORGANIZATION | 43 | 558 | 3.204e-06 | 0.0002293 |
66 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 24 | 229 | 3.46e-06 | 0.0002303 |
67 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 42 | 541 | 3.464e-06 | 0.0002303 |
68 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 42 | 541 | 3.464e-06 | 0.0002303 |
69 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 59 | 872 | 3.403e-06 | 0.0002303 |
70 | REGULATION OF GTPASE ACTIVITY | 49 | 673 | 3.29e-06 | 0.0002303 |
71 | CELLULAR HOMEOSTASIS | 49 | 676 | 3.72e-06 | 0.0002438 |
72 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 63 | 957 | 3.838e-06 | 0.000248 |
73 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 38 | 470 | 3.957e-06 | 0.0002522 |
74 | RESPONSE TO NITROGEN COMPOUND | 58 | 859 | 4.399e-06 | 0.0002693 |
75 | POSITIVE REGULATION OF CELL DEVELOPMENT | 38 | 472 | 4.37e-06 | 0.0002693 |
76 | MESONEPHROS DEVELOPMENT | 14 | 90 | 4.345e-06 | 0.0002693 |
77 | CELLULAR CATABOLIC PROCESS | 80 | 1322 | 4.697e-06 | 0.0002838 |
78 | ORGAN MORPHOGENESIS | 57 | 841 | 4.76e-06 | 0.0002839 |
79 | POSITIVE REGULATION OF LOCOMOTION | 35 | 420 | 4.9e-06 | 0.0002886 |
80 | NEGATIVE REGULATION OF KINASE ACTIVITY | 25 | 250 | 5.055e-06 | 0.0002938 |
81 | STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 173 | 5.114e-06 | 0.0002938 |
82 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 31 | 352 | 5.613e-06 | 0.0003185 |
83 | CELLULAR RESPONSE TO HORMONE STIMULUS | 42 | 552 | 5.714e-06 | 0.0003203 |
84 | HEAD DEVELOPMENT | 50 | 709 | 6.34e-06 | 0.0003502 |
85 | IRON ION HOMEOSTASIS | 12 | 69 | 6.398e-06 | 0.0003502 |
86 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 34 | 408 | 6.679e-06 | 0.0003613 |
87 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 71 | 1142 | 6.763e-06 | 0.0003617 |
88 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 58 | 876 | 7.944e-06 | 0.0004153 |
89 | REGULATION OF OSSIFICATION | 20 | 178 | 7.887e-06 | 0.0004153 |
90 | REGULATION OF HYDROLASE ACTIVITY | 79 | 1327 | 9.801e-06 | 0.0005067 |
91 | INTRINSIC APOPTOTIC SIGNALING PATHWAY | 18 | 152 | 1.074e-05 | 0.0005493 |
92 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 26 | 278 | 1.103e-05 | 0.000558 |
93 | SKELETAL SYSTEM DEVELOPMENT | 36 | 455 | 1.141e-05 | 0.0005707 |
94 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 35 | 437 | 1.161e-05 | 0.0005748 |
95 | KIDNEY EPITHELIUM DEVELOPMENT | 16 | 125 | 1.227e-05 | 0.000601 |
96 | TUBE DEVELOPMENT | 41 | 552 | 1.31e-05 | 0.0006219 |
97 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 20 | 184 | 1.296e-05 | 0.0006219 |
98 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 41 | 552 | 1.31e-05 | 0.0006219 |
99 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 51 | 750 | 1.391e-05 | 0.0006539 |
100 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 38 | 498 | 1.489e-05 | 0.0006908 |
101 | RESPONSE TO OXIDATIVE STRESS | 30 | 352 | 1.499e-05 | 0.0006908 |
102 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 70 | 1152 | 1.681e-05 | 0.0007669 |
103 | REGULATION OF MAPK CASCADE | 46 | 660 | 2.002e-05 | 0.0008882 |
104 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 53 | 801 | 2.004e-05 | 0.0008882 |
105 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 6 | 17 | 1.984e-05 | 0.0008882 |
106 | MACROMOLECULE CATABOLIC PROCESS | 59 | 926 | 2.073e-05 | 0.00091 |
107 | PROTEIN LOCALIZATION | 99 | 1805 | 2.144e-05 | 0.0009322 |
108 | NEGATIVE REGULATION OF CELL PROLIFERATION | 45 | 643 | 2.227e-05 | 0.0009594 |
109 | NEGATIVE REGULATION OF CELL ADHESION | 22 | 223 | 2.273e-05 | 0.0009684 |
110 | PHOSPHORYLATION | 73 | 1228 | 2.289e-05 | 0.0009684 |
111 | NEURON DEVELOPMENT | 47 | 687 | 2.602e-05 | 0.001088 |
112 | MUSCLE TISSUE DEVELOPMENT | 25 | 275 | 2.619e-05 | 0.001088 |
113 | CEREBRAL CORTEX DEVELOPMENT | 14 | 105 | 2.669e-05 | 0.001099 |
114 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 43 | 609 | 2.746e-05 | 0.001121 |
115 | ENTRAINMENT OF CIRCADIAN CLOCK | 7 | 26 | 2.927e-05 | 0.001184 |
116 | CELL DEATH | 62 | 1001 | 2.973e-05 | 0.001193 |
117 | REGULATION OF DENDRITE DEVELOPMENT | 15 | 120 | 3.03e-05 | 0.001205 |
118 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 80 | 1395 | 3.223e-05 | 0.001271 |
119 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 26 | 296 | 3.287e-05 | 0.001285 |
120 | ION HOMEOSTASIS | 41 | 576 | 3.505e-05 | 0.001359 |
121 | PROTEIN PHOSPHORYLATION | 59 | 944 | 3.605e-05 | 0.001386 |
122 | REGULATION OF CYTOPLASMIC TRANSPORT | 36 | 481 | 3.735e-05 | 0.001424 |
123 | CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 7 | 27 | 3.829e-05 | 0.001448 |
124 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 57 | 905 | 3.959e-05 | 0.001486 |
125 | REGULATION OF BINDING | 25 | 283 | 4.218e-05 | 0.00157 |
126 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 74 | 1275 | 4.415e-05 | 0.00163 |
127 | CATABOLIC PROCESS | 96 | 1773 | 4.756e-05 | 0.001743 |
128 | EPITHELIAL CELL DEVELOPMENT | 19 | 186 | 5.029e-05 | 0.001828 |
129 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 126 | 5.39e-05 | 0.001944 |
130 | ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 6 | 20 | 5.658e-05 | 0.00201 |
131 | REGULATION OF TRANSPORT | 97 | 1804 | 5.64e-05 | 0.00201 |
132 | REGULATION OF CELL SIZE | 18 | 172 | 5.737e-05 | 0.002015 |
133 | RESPONSE TO ABIOTIC STIMULUS | 62 | 1024 | 5.759e-05 | 0.002015 |
134 | REGULATION OF CELL ADHESION | 43 | 629 | 5.818e-05 | 0.00202 |
135 | TISSUE MORPHOGENESIS | 38 | 533 | 6.509e-05 | 0.002227 |
136 | MUSCLE CELL DEVELOPMENT | 15 | 128 | 6.474e-05 | 0.002227 |
137 | CELLULAR RESPONSE TO OXYGEN LEVELS | 16 | 143 | 6.572e-05 | 0.002232 |
138 | EPITHELIAL CELL DIFFERENTIATION | 36 | 495 | 6.744e-05 | 0.002274 |
139 | CELL PROJECTION ORGANIZATION | 56 | 902 | 6.823e-05 | 0.002284 |
140 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 84 | 1517 | 6.935e-05 | 0.002305 |
141 | REGULATION OF DENDRITE MORPHOGENESIS | 11 | 74 | 7.041e-05 | 0.002307 |
142 | REGULATION OF JNK CASCADE | 17 | 159 | 6.992e-05 | 0.002307 |
143 | ANGIOGENESIS | 25 | 293 | 7.424e-05 | 0.002416 |
144 | REGULATION OF CELLULAR LOCALIZATION | 73 | 1277 | 8.048e-05 | 0.002547 |
145 | REGULATION OF PROTEIN LOCALIZATION | 58 | 950 | 8.004e-05 | 0.002547 |
146 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 52 | 823 | 7.982e-05 | 0.002547 |
147 | POSITIVE REGULATION OF AUTOPHAGY | 11 | 75 | 7.984e-05 | 0.002547 |
148 | DEVELOPMENTAL MATURATION | 19 | 193 | 8.299e-05 | 0.002609 |
149 | ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 35 | 482 | 8.745e-05 | 0.002731 |
150 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 28 | 351 | 9.149e-05 | 0.002838 |
151 | RHYTHMIC PROCESS | 25 | 298 | 9.732e-05 | 0.002999 |
152 | REGULATION OF CELL MATRIX ADHESION | 12 | 90 | 9.911e-05 | 0.003034 |
153 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 36 | 505 | 0.0001009 | 0.003069 |
154 | UROGENITAL SYSTEM DEVELOPMENT | 25 | 299 | 0.0001026 | 0.003101 |
155 | NEURON PROJECTION DEVELOPMENT | 38 | 545 | 0.0001036 | 0.003104 |
156 | POSITIVE REGULATION OF CELL DEATH | 41 | 605 | 0.0001041 | 0.003104 |
157 | REGULATION OF RESPONSE TO STRESS | 81 | 1468 | 0.0001059 | 0.003139 |
158 | NEGATIVE REGULATION OF GENE EXPRESSION | 82 | 1493 | 0.0001116 | 0.003285 |
159 | REGULATION OF CELLULAR COMPONENT SIZE | 27 | 337 | 0.000113 | 0.003285 |
160 | LOCOMOTION | 65 | 1114 | 0.0001124 | 0.003285 |
161 | REGULATION OF PROTEIN CATABOLIC PROCESS | 30 | 393 | 0.000115 | 0.003323 |
162 | REGULATION OF CELL PROLIFERATION | 82 | 1496 | 0.0001192 | 0.003424 |
163 | NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 32 | 0.0001239 | 0.003514 |
164 | POSITIVE REGULATION OF DENDRITE MORPHOGENESIS | 7 | 32 | 0.0001239 | 0.003514 |
165 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 34 | 472 | 0.0001281 | 0.00359 |
166 | RESPONSE TO EXTERNAL STIMULUS | 96 | 1821 | 0.0001279 | 0.00359 |
167 | PROTEOLYSIS | 69 | 1208 | 0.0001301 | 0.003625 |
168 | REGULATION OF CELL MORPHOGENESIS | 38 | 552 | 0.0001345 | 0.003726 |
169 | CELLULAR MACROMOLECULE LOCALIZATION | 70 | 1234 | 0.0001426 | 0.003926 |
170 | RESPONSE TO GROWTH FACTOR | 34 | 475 | 0.0001445 | 0.003954 |
171 | SPHINGOLIPID METABOLIC PROCESS | 15 | 138 | 0.0001527 | 0.004118 |
172 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 41 | 616 | 0.0001531 | 0.004118 |
173 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 41 | 616 | 0.0001531 | 0.004118 |
174 | REGULATION OF DEVELOPMENTAL GROWTH | 24 | 289 | 0.0001555 | 0.004135 |
175 | APOPTOTIC SIGNALING PATHWAY | 24 | 289 | 0.0001555 | 0.004135 |
176 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 15 | 140 | 0.0001793 | 0.00474 |
177 | CELLULAR RESPONSE TO PEPTIDE | 23 | 274 | 0.0001809 | 0.004755 |
178 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 34 | 0.0001859 | 0.004778 |
179 | RESPONSE TO FLUID SHEAR STRESS | 7 | 34 | 0.0001859 | 0.004778 |
180 | ER NUCLEUS SIGNALING PATHWAY | 7 | 34 | 0.0001859 | 0.004778 |
181 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 16 | 156 | 0.0001843 | 0.004778 |
182 | RESPONSE TO OXYGEN LEVELS | 25 | 311 | 0.00019 | 0.004858 |
183 | REGULATION OF CELL SUBSTRATE ADHESION | 17 | 173 | 0.0001974 | 0.004991 |
184 | CELLULAR RESPONSE TO STRESS | 84 | 1565 | 0.0001963 | 0.004991 |
185 | POST GOLGI VESICLE MEDIATED TRANSPORT | 11 | 83 | 0.0002023 | 0.005073 |
186 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 28 | 368 | 0.0002028 | 0.005073 |
187 | CELLULAR COMPONENT MORPHOGENESIS | 54 | 900 | 0.0002177 | 0.005416 |
188 | INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 10 | 71 | 0.0002357 | 0.005832 |
189 | PROTEIN UBIQUITINATION | 41 | 629 | 0.0002373 | 0.005842 |
190 | RESPONSE TO MECHANICAL STIMULUS | 19 | 210 | 0.0002509 | 0.006143 |
191 | POSITIVE REGULATION OF MAPK CASCADE | 33 | 470 | 0.0002559 | 0.006171 |
192 | CELL JUNCTION ASSEMBLY | 14 | 129 | 0.0002549 | 0.006171 |
193 | CELLULAR CHEMICAL HOMEOSTASIS | 38 | 570 | 0.000256 | 0.006171 |
194 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 22 | 263 | 0.0002603 | 0.006242 |
195 | REGULATION OF GROWTH | 41 | 633 | 0.0002705 | 0.006428 |
196 | POSITIVE REGULATION OF AXON EXTENSION | 7 | 36 | 0.0002708 | 0.006428 |
197 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 26 | 337 | 0.0002725 | 0.006435 |
198 | REGULATION OF LIPID METABOLIC PROCESS | 23 | 282 | 0.0002747 | 0.006456 |
199 | NEGATIVE REGULATION OF CELL CYCLE | 31 | 433 | 0.0002788 | 0.006518 |
200 | ESTABLISHMENT OF LOCALIZATION IN CELL | 88 | 1676 | 0.0002857 | 0.006581 |
201 | CELLULAR RESPONSE TO INSULIN STIMULUS | 15 | 146 | 0.0002846 | 0.006581 |
202 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 16 | 162 | 0.0002842 | 0.006581 |
203 | PROTEIN STABILIZATION | 14 | 131 | 0.0002993 | 0.006859 |
204 | COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 8 | 48 | 0.0003052 | 0.006895 |
205 | POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 8 | 48 | 0.0003052 | 0.006895 |
206 | POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 8 | 48 | 0.0003052 | 0.006895 |
207 | REGULATION OF CELL DEATH | 79 | 1472 | 0.0003081 | 0.006925 |
208 | GOLGI TO VACUOLE TRANSPORT | 6 | 27 | 0.0003477 | 0.007778 |
209 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 14 | 133 | 0.0003501 | 0.007794 |
210 | REGULATION OF INTRACELLULAR TRANSPORT | 40 | 621 | 0.0003578 | 0.007928 |
211 | REGULATION OF CIRCADIAN RHYTHM | 12 | 103 | 0.0003603 | 0.007945 |
212 | NEURON PROJECTION MORPHOGENESIS | 29 | 402 | 0.0003829 | 0.008404 |
213 | POSITIVE REGULATION OF KINASE ACTIVITY | 33 | 482 | 0.0004015 | 0.00873 |
214 | REGULATION OF VESICLE MEDIATED TRANSPORT | 32 | 462 | 0.0004001 | 0.00873 |
215 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 14 | 135 | 0.0004081 | 0.008812 |
216 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 17 | 184 | 0.0004091 | 0.008812 |
217 | RESPONSE TO PEPTIDE | 29 | 404 | 0.0004152 | 0.008902 |
218 | VACUOLE ORGANIZATION | 16 | 168 | 0.000428 | 0.009106 |
219 | MUSCLE HYPERTROPHY | 6 | 28 | 0.000429 | 0.009106 |
220 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 9 | 63 | 0.0004306 | 0.009106 |
221 | VESICLE CYTOSKELETAL TRAFFICKING | 7 | 39 | 0.0004539 | 0.009556 |
222 | POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 11 | 0.0004658 | 0.009722 |
223 | LYTIC VACUOLE ORGANIZATION | 8 | 51 | 0.000468 | 0.009722 |
224 | LYSOSOME ORGANIZATION | 8 | 51 | 0.000468 | 0.009722 |
225 | CIRCADIAN RHYTHM | 14 | 137 | 0.0004741 | 0.009805 |
226 | REGULATION OF PROTEIN STABILITY | 19 | 221 | 0.0004768 | 0.009816 |
227 | REGULATION OF HOMEOSTATIC PROCESS | 31 | 447 | 0.0004798 | 0.009834 |
228 | POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 9 | 64 | 0.0004851 | 0.0099 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 121 | 1737 | 1.633e-12 | 1.517e-09 |
2 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 31 | 328 | 1.293e-06 | 0.0006006 |
3 | MACROMOLECULAR COMPLEX BINDING | 85 | 1399 | 1.964e-06 | 0.0006081 |
4 | CYTOSKELETAL PROTEIN BINDING | 56 | 819 | 4.45e-06 | 0.001034 |
5 | UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY | 33 | 420 | 3.017e-05 | 0.004004 |
6 | PROTEIN HOMODIMERIZATION ACTIVITY | 49 | 722 | 2.159e-05 | 0.004004 |
7 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 44 | 629 | 2.775e-05 | 0.004004 |
8 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 24 | 264 | 3.775e-05 | 0.004384 |
9 | IDENTICAL PROTEIN BINDING | 71 | 1209 | 4.393e-05 | 0.004535 |
10 | PROTEIN DIMERIZATION ACTIVITY | 68 | 1149 | 5.068e-05 | 0.004708 |
11 | CALCIUM ION BINDING | 46 | 697 | 7.517e-05 | 0.006349 |
12 | PROTEIN KINASE ACTIVITY | 43 | 640 | 8.618e-05 | 0.006672 |
13 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 13 | 104 | 0.0001012 | 0.007231 |
14 | RECEPTOR BINDING | 81 | 1476 | 0.0001265 | 0.008395 |
15 | KINASE ACTIVITY | 52 | 842 | 0.0001412 | 0.008747 |
16 | PROTEIN COMPLEX BINDING | 56 | 935 | 0.0001745 | 0.009533 |
17 | MOLECULAR FUNCTION REGULATOR | 75 | 1353 | 0.0001679 | 0.009533 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MEMBRANE REGION | 80 | 1134 | 8.963e-09 | 5.235e-06 |
2 | MEMBRANE MICRODOMAIN | 30 | 288 | 2.443e-07 | 7.134e-05 |
3 | NEURON PART | 81 | 1265 | 4.484e-07 | 8.729e-05 |
4 | CELL LEADING EDGE | 33 | 350 | 6.236e-07 | 9.104e-05 |
5 | ACTIN CYTOSKELETON | 38 | 444 | 1.015e-06 | 0.0001185 |
6 | PERINUCLEAR REGION OF CYTOPLASM | 47 | 642 | 4.518e-06 | 0.0004397 |
7 | NEURON PROJECTION | 61 | 942 | 9.152e-06 | 0.0007636 |
8 | VACUOLE | 72 | 1180 | 1.1e-05 | 0.0008033 |
9 | ENDOPLASMIC RETICULUM | 92 | 1631 | 1.495e-05 | 0.0009698 |
10 | LAMELLIPODIUM | 19 | 172 | 1.686e-05 | 0.0009844 |
11 | PLASMA MEMBRANE REGION | 59 | 929 | 2.277e-05 | 0.001108 |
12 | GOLGI APPARATUS | 83 | 1445 | 2.14e-05 | 0.001108 |
13 | ENDOSOME | 52 | 793 | 3.051e-05 | 0.001371 |
14 | CYTOSKELETON | 105 | 1967 | 3.6e-05 | 0.001502 |
15 | CELL PROJECTION | 96 | 1786 | 6.264e-05 | 0.002439 |
16 | SYNAPSE | 48 | 754 | 0.0001254 | 0.004487 |
17 | CELL PROJECTION PART | 57 | 946 | 0.0001306 | 0.004487 |
18 | UBIQUITIN LIGASE COMPLEX | 22 | 262 | 0.0002467 | 0.007105 |
19 | CELL JUNCTION | 65 | 1151 | 0.0002798 | 0.007105 |
20 | CORTICAL ACTIN CYTOSKELETON | 9 | 58 | 0.0002277 | 0.007105 |
21 | MICROTUBULE PLUS END | 5 | 17 | 0.0002691 | 0.007105 |
22 | CATALYTIC COMPLEX | 60 | 1038 | 0.0002644 | 0.007105 |
23 | PLASMA MEMBRANE RAFT | 11 | 86 | 0.0002779 | 0.007105 |
24 | TRANSFERASE COMPLEX | 44 | 703 | 0.0003428 | 0.008341 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04010_MAPK_signaling_pathway | 25 | 268 | 1.694e-05 | 0.001724 | |
2 | hsa04210_Apoptosis | 13 | 89 | 1.915e-05 | 0.001724 | |
3 | hsa04710_Circadian_rhythm_._mammal | 6 | 23 | 0.0001342 | 0.008054 | |
4 | hsa04151_PI3K_AKT_signaling_pathway | 26 | 351 | 0.0005075 | 0.02284 | |
5 | hsa04115_p53_signaling_pathway | 9 | 69 | 0.0008498 | 0.03059 | |
6 | hsa04510_Focal_adhesion | 17 | 200 | 0.001052 | 0.03155 | |
7 | hsa04360_Axon_guidance | 12 | 130 | 0.002799 | 0.07198 | |
8 | hsa04380_Osteoclast_differentiation | 11 | 128 | 0.007041 | 0.1493 | |
9 | hsa04144_Endocytosis | 15 | 203 | 0.007464 | 0.1493 | |
10 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 13 | 168 | 0.008506 | 0.1531 | |
11 | hsa04390_Hippo_signaling_pathway | 12 | 154 | 0.01064 | 0.1603 | |
12 | hsa04912_GnRH_signaling_pathway | 9 | 101 | 0.01127 | 0.1603 | |
13 | hsa04920_Adipocytokine_signaling_pathway | 7 | 68 | 0.01158 | 0.1603 | |
14 | hsa04014_Ras_signaling_pathway | 16 | 236 | 0.01277 | 0.1642 | |
15 | hsa04914_Progesterone.mediated_oocyte_maturation | 8 | 87 | 0.01377 | 0.1652 | |
16 | hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series | 3 | 15 | 0.0157 | 0.1766 | |
17 | hsa00071_Fatty_acid_metabolism | 5 | 43 | 0.01926 | 0.1997 | |
18 | hsa00340_Histidine_metabolism | 4 | 29 | 0.01997 | 0.1997 | |
19 | hsa04114_Oocyte_meiosis | 9 | 114 | 0.02321 | 0.2199 | |
20 | hsa04270_Vascular_smooth_muscle_contraction | 9 | 116 | 0.02564 | 0.2307 | |
21 | hsa04910_Insulin_signaling_pathway | 10 | 138 | 0.02927 | 0.2509 | |
22 | hsa04350_TGF.beta_signaling_pathway | 7 | 85 | 0.03498 | 0.2822 | |
23 | hsa04150_mTOR_signaling_pathway | 5 | 52 | 0.03995 | 0.2822 | |
24 | hsa03320_PPAR_signaling_pathway | 6 | 70 | 0.04161 | 0.2822 | |
25 | hsa04722_Neurotrophin_signaling_pathway | 9 | 127 | 0.04223 | 0.2822 | |
26 | hsa04970_Salivary_secretion | 7 | 89 | 0.04323 | 0.2822 | |
27 | hsa00410_beta.Alanine_metabolism | 3 | 22 | 0.04406 | 0.2822 | |
28 | hsa04976_Bile_secretion | 6 | 71 | 0.04412 | 0.2822 | |
29 | hsa04540_Gap_junction | 7 | 90 | 0.04547 | 0.2822 | |
30 | hsa04662_B_cell_receptor_signaling_pathway | 6 | 75 | 0.05507 | 0.3304 | |
31 | hsa04260_Cardiac_muscle_contraction | 6 | 77 | 0.0611 | 0.3548 | |
32 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 4 | 42 | 0.0653 | 0.3673 | |
33 | hsa04142_Lysosome | 8 | 121 | 0.0741 | 0.3753 | |
34 | hsa04962_Vasopressin.regulated_water_reabsorption | 4 | 44 | 0.07491 | 0.3753 | |
35 | hsa04973_Carbohydrate_digestion_and_absorption | 4 | 44 | 0.07491 | 0.3753 | |
36 | hsa04972_Pancreatic_secretion | 7 | 101 | 0.07506 | 0.3753 | |
37 | hsa04062_Chemokine_signaling_pathway | 11 | 189 | 0.08469 | 0.412 | |
38 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 3 | 30 | 0.09412 | 0.4284 | |
39 | hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism | 4 | 48 | 0.09613 | 0.4284 | |
40 | hsa04012_ErbB_signaling_pathway | 6 | 87 | 0.0969 | 0.4284 | |
41 | hsa04660_T_cell_receptor_signaling_pathway | 7 | 108 | 0.09865 | 0.4284 | |
42 | hsa04310_Wnt_signaling_pathway | 9 | 151 | 0.09995 | 0.4284 | |
43 | hsa04720_Long.term_potentiation | 5 | 70 | 0.1108 | 0.443 | |
44 | hsa04020_Calcium_signaling_pathway | 10 | 177 | 0.1121 | 0.443 | |
45 | hsa04630_Jak.STAT_signaling_pathway | 9 | 155 | 0.1126 | 0.443 | |
46 | hsa00770_Pantothenate_and_CoA_biosynthesis | 2 | 16 | 0.1132 | 0.443 | |
47 | hsa04971_Gastric_acid_secretion | 5 | 74 | 0.1316 | 0.4869 | |
48 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 6 | 95 | 0.132 | 0.4869 | |
49 | hsa00500_Starch_and_sucrose_metabolism | 4 | 54 | 0.1325 | 0.4869 | |
50 | hsa00565_Ether_lipid_metabolism | 3 | 36 | 0.1417 | 0.5034 | |
51 | hsa04370_VEGF_signaling_pathway | 5 | 76 | 0.1426 | 0.5034 | |
52 | hsa04810_Regulation_of_actin_cytoskeleton | 11 | 214 | 0.1578 | 0.543 | |
53 | hsa04146_Peroxisome | 5 | 79 | 0.1599 | 0.543 | |
54 | hsa00592_alpha.Linolenic_acid_metabolism | 2 | 20 | 0.1633 | 0.5445 | |
55 | hsa00350_Tyrosine_metabolism | 3 | 41 | 0.1862 | 0.6093 | |
56 | hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate | 2 | 22 | 0.1897 | 0.6096 | |
57 | hsa04964_Proximal_tubule_bicarbonate_reclamation | 2 | 23 | 0.203 | 0.6301 | |
58 | hsa00010_Glycolysis_._Gluconeogenesis | 4 | 65 | 0.2108 | 0.6388 | |
59 | hsa00280_Valine._leucine_and_isoleucine_degradation | 3 | 44 | 0.2144 | 0.6388 | |
60 | hsa00760_Nicotinate_and_nicotinamide_metabolism | 2 | 24 | 0.2165 | 0.6388 | |
61 | hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate | 2 | 26 | 0.2436 | 0.696 | |
62 | hsa04730_Long.term_depression | 4 | 70 | 0.2499 | 0.7029 | |
63 | hsa00052_Galactose_metabolism | 2 | 27 | 0.2572 | 0.7123 | |
64 | hsa00561_Glycerolipid_metabolism | 3 | 50 | 0.273 | 0.7447 | |
65 | hsa04916_Melanogenesis | 5 | 101 | 0.3059 | 0.8096 | |
66 | hsa04620_Toll.like_receptor_signaling_pathway | 5 | 102 | 0.313 | 0.8129 | |
67 | hsa04664_Fc_epsilon_RI_signaling_pathway | 4 | 79 | 0.3234 | 0.8129 | |
68 | hsa00040_Pentose_and_glucuronate_interconversions | 2 | 32 | 0.3251 | 0.8129 | |
69 | hsa00640_Propanoate_metabolism | 2 | 32 | 0.3251 | 0.8129 | |
70 | hsa04514_Cell_adhesion_molecules_.CAMs. | 6 | 136 | 0.3739 | 0.873 | |
71 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 6 | 136 | 0.3739 | 0.873 | |
72 | hsa00230_Purine_metabolism | 7 | 162 | 0.3754 | 0.873 | |
73 | hsa00051_Fructose_and_mannose_metabolism | 2 | 36 | 0.3783 | 0.873 | |
74 | hsa04130_SNARE_interactions_in_vesicular_transport | 2 | 36 | 0.3783 | 0.873 | |
75 | hsa00310_Lysine_degradation | 2 | 44 | 0.4787 | 0.9676 | |
76 | hsa00240_Pyrimidine_metabolism | 4 | 99 | 0.4872 | 0.9676 | |
77 | hsa04520_Adherens_junction | 3 | 73 | 0.4982 | 0.9676 | |
78 | hsa04110_Cell_cycle | 5 | 128 | 0.4993 | 0.9676 | |
79 | hsa04975_Fat_digestion_and_absorption | 2 | 46 | 0.5022 | 0.9676 | |
80 | hsa00190_Oxidative_phosphorylation | 5 | 132 | 0.5266 | 0.9972 | |
81 | hsa04530_Tight_junction | 5 | 133 | 0.5333 | 0.9972 | |
82 | hsa04070_Phosphatidylinositol_signaling_system | 3 | 78 | 0.5429 | 0.9972 | |
83 | hsa00564_Glycerophospholipid_metabolism | 3 | 80 | 0.5602 | 1 | |
84 | hsa00983_Drug_metabolism_._other_enzymes | 2 | 52 | 0.5685 | 1 | |
85 | hsa04120_Ubiquitin_mediated_proteolysis | 5 | 139 | 0.5727 | 1 | |
86 | hsa04340_Hedgehog_signaling_pathway | 2 | 56 | 0.609 | 1 | |
87 | hsa00590_Arachidonic_acid_metabolism | 2 | 59 | 0.6375 | 1 | |
88 | hsa04145_Phagosome | 5 | 156 | 0.674 | 1 | |
89 | hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 | 2 | 71 | 0.7351 | 1 | |
90 | hsa03018_RNA_degradation | 2 | 71 | 0.7351 | 1 | |
91 | hsa00982_Drug_metabolism_._cytochrome_P450 | 2 | 73 | 0.749 | 1 | |
92 | hsa04612_Antigen_processing_and_presentation | 2 | 78 | 0.7811 | 1 | |
93 | hsa03008_Ribosome_biogenesis_in_eukaryotes | 2 | 81 | 0.7985 | 1 | |
94 | hsa04974_Protein_digestion_and_absorption | 2 | 81 | 0.7985 | 1 | |
95 | hsa04670_Leukocyte_transendothelial_migration | 3 | 117 | 0.8028 | 1 | |
96 | hsa03015_mRNA_surveillance_pathway | 2 | 83 | 0.8095 | 1 | |
97 | hsa04512_ECM.receptor_interaction | 2 | 85 | 0.8199 | 1 |